
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Esophagogastric Junction Adenocarcinoma
View Full LandscapeTarget Indication
Esophagogastric Junction Adenocarcinoma
Clinical Trial
NCT00719550Last updated: 6/24/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Psoriatic Arthritis
Anemia
Head and Neck Cancer
Newly Diagnosed Philadelphia (Ph)-Negative B-cell Precursor Acute Lymphoblastic Leukemia (ALL)
Relapsed and Refractory Multiple Myeloma